0 évaluation0% ont trouvé ce document utile (0 vote)
11 vues1 page
This document discusses a study that simultaneously demonstrated the activation of presynaptic dopamine autoreceptors and postsynaptic dopamine receptors in vitro by N,N-dipropyl-5,6-ADTN. Specifically, it reports that the compound inhibited the release of both acetylcholine (indicating activation of postsynaptic dopamine receptors) and dopamine (indicating activation of presynaptic dopamine autoreceptors) from rat caudate nucleus slices. This provides evidence that N,N-dipropyl-5,6-ADTN can activate both pre- and postsynaptic dopamine receptors in the neostriatum.
Description originale:
Activation of Dopamine Receptors in the neostriatum inhibits acetylcholine release
Titre original
Activation of Dopamine Receptors in the Neostriatum Inhibits Acetylcholine Release
This document discusses a study that simultaneously demonstrated the activation of presynaptic dopamine autoreceptors and postsynaptic dopamine receptors in vitro by N,N-dipropyl-5,6-ADTN. Specifically, it reports that the compound inhibited the release of both acetylcholine (indicating activation of postsynaptic dopamine receptors) and dopamine (indicating activation of presynaptic dopamine autoreceptors) from rat caudate nucleus slices. This provides evidence that N,N-dipropyl-5,6-ADTN can activate both pre- and postsynaptic dopamine receptors in the neostriatum.
This document discusses a study that simultaneously demonstrated the activation of presynaptic dopamine autoreceptors and postsynaptic dopamine receptors in vitro by N,N-dipropyl-5,6-ADTN. Specifically, it reports that the compound inhibited the release of both acetylcholine (indicating activation of postsynaptic dopamine receptors) and dopamine (indicating activation of presynaptic dopamine autoreceptors) from rat caudate nucleus slices. This provides evidence that N,N-dipropyl-5,6-ADTN can activate both pre- and postsynaptic dopamine receptors in the neostriatum.
Simultaneous demonstration of the activation of presynaptic dopamine
autoreceptors and postsynaptic dopamine receptors in vitro by N,N -dipropyl-5,6-ADTN
JOHANNES C. STOOF, ALAN S. HORN and ARIE H. MULDER
Departments of Neurology and Pharmacology, Free University Medical Faculty, van der Boeehorststraat 7, 1081 BT Amsterdam and (A. S. H.) Department of Pharmacy, University of Groningen, Antonius Deusinglaan 2, Groningen (The Netherlands) (Accepted April 17th, 1980)
Several lines of evidence indicate that in the neostriatum activation of post-
synaptic dopamine (DA) receptors inhibits the release of acetylcholine (ACh)from cholinergic interneurones. For instance, it has been reported that neostriatal ACh levels were increased after pretreatment with the DA receptor agonist apomorphine, and decreased after pretreatment with neuroleptics such as haloperidol and chlorpro- mazinen,l°,lL Moreover, using the push-puU cannula technique, Bartholini et al. 2 have shown that apomorphine or L-DOPA inhibit ACh release from cat neostriatum and that these inhibitory effects are antagonized by neuroleptics. In accordance with these data we have recently found zl that the depolarization-induced release of radio- labelled ACh from neostriatal slices was inhibited by various DA receptor agonists, and that these inhibitory effects were antagonized by haloperidol. It was further demonstrated that supersensitivity of the DA receptors involved developed following neonatal treatment with 6-hydroxydopamine. Based on these data we suggested that ACh release from neostriatal slices provides a functional in vitro parameter to investigate the activity of drugs on postsynaptic DA receptors 21. In addition to postsynaptic DA receptors, the existence of DA receptors on dopaminergic nerve terminals (i.e. auto-receptors) has been proposed. These DA auto- receptors are thought to regulate DA synthesis and release by a local negative feed- back mechanism. For instance, DA receptor agonists have been shown to inhibit DA synthesis from radiolabelled tyrosine in striatal slices or synaptosomal prepara- tionsS,la, 22. On the other hand, in view of conflicting evidence the existence of DA auto-receptors, which inhibit transmitter release directly, i.e. not as a result of the inhi- bition of DA synthesis, is still a matter of controversy. Thus, a number of groups~,16,19 have reported that D A receptor agonists inhibit the release of radiolabelled DA from striatal slices, while othersX,14, a7 did not observe such an inhibition of DA release.